DE102004016179A1 - Verbindungen zur Behandlung von proliferativen Prozessen - Google Patents
Verbindungen zur Behandlung von proliferativen Prozessen Download PDFInfo
- Publication number
- DE102004016179A1 DE102004016179A1 DE102004016179A DE102004016179A DE102004016179A1 DE 102004016179 A1 DE102004016179 A1 DE 102004016179A1 DE 102004016179 A DE102004016179 A DE 102004016179A DE 102004016179 A DE102004016179 A DE 102004016179A DE 102004016179 A1 DE102004016179 A1 DE 102004016179A1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- compounds
- proliferative processes
- proliferative
- processes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
Die Erfindung betrifft die Verwendung von Anticholinergika zur Herstellung eines Arzneimittels zur Vorbeugung und Behandlung proliferativer Prozesse.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004016179A DE102004016179A1 (de) | 2004-03-30 | 2004-03-30 | Verbindungen zur Behandlung von proliferativen Prozessen |
US11/074,179 US20060030579A1 (en) | 2004-03-30 | 2005-03-07 | Compounds for the treatment of proliverative processes |
JP2007505432A JP2007530611A (ja) | 2004-03-30 | 2005-03-19 | 増殖性過程の治療用化合物 |
CA002560131A CA2560131A1 (en) | 2004-03-30 | 2005-03-19 | Compounds for treating proliferative processes |
EP05716229A EP1732553A1 (de) | 2004-03-30 | 2005-03-19 | Verbindungen zur behandlung von proliferativen prozessen |
PCT/EP2005/002946 WO2005097126A1 (de) | 2004-03-30 | 2005-03-19 | Verbindungen zur behandlung von proliferativen prozessen |
US12/963,250 US20110076238A1 (en) | 2004-03-30 | 2010-12-08 | Compounds for the treatment of proliferative processes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004016179A DE102004016179A1 (de) | 2004-03-30 | 2004-03-30 | Verbindungen zur Behandlung von proliferativen Prozessen |
Publications (1)
Publication Number | Publication Date |
---|---|
DE102004016179A1 true DE102004016179A1 (de) | 2005-10-20 |
Family
ID=34962915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE102004016179A Withdrawn DE102004016179A1 (de) | 2004-03-30 | 2004-03-30 | Verbindungen zur Behandlung von proliferativen Prozessen |
Country Status (6)
Country | Link |
---|---|
US (2) | US20060030579A1 (de) |
EP (1) | EP1732553A1 (de) |
JP (1) | JP2007530611A (de) |
CA (1) | CA2560131A1 (de) |
DE (1) | DE102004016179A1 (de) |
WO (1) | WO2005097126A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
US20060079544A1 (en) * | 2004-08-13 | 2006-04-13 | Boehringer Ingelheim International Gmbh | Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic |
US20090062326A1 (en) * | 2006-03-17 | 2009-03-05 | Spindel Eliot R | M3 muscarinic receptor antagonists for treatment of m3 muscarinic receptor-expressing tumors |
NZ578473A (en) * | 2007-02-21 | 2011-10-28 | Almirall Sa | Aclinidium for use in respiratory disease |
EP2100599A1 (de) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung |
EP2100598A1 (de) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung |
EP2510928A1 (de) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten |
US10111957B2 (en) | 2012-07-05 | 2018-10-30 | Arven Ilac Snayi ve Ticaret A.S. | Inhalation compositions comprising glucose anhydrous |
US20150202148A1 (en) * | 2012-07-05 | 2015-07-23 | Arven llac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhalers comprising a carrier other than lactose |
US20150202297A1 (en) * | 2012-07-05 | 2015-07-23 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhalers comprising a carrier other than lactose and a ternary component |
US10105316B2 (en) | 2012-07-05 | 2018-10-23 | Arven llac Sanayi Ve Ticaret A.S. | Inhalation compositions comprising muscarinic receptor antagonist |
CZ2014188A3 (cs) | 2014-03-26 | 2015-10-07 | Zentiva, K.S. | Nové formy aclidinium chloridu a způsob jejich přípravy |
US20210030868A1 (en) * | 2019-07-29 | 2021-02-04 | Cai Gu Huang | Formulation of antibody based drugs for treating lung cancer by inhalation |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9902689D0 (en) * | 1999-02-08 | 1999-03-31 | Novartis Ag | Organic compounds |
GB9918760D0 (en) * | 1999-08-09 | 1999-10-13 | Darwin Discovery Ltd | Topical treatment |
TR200402579T4 (tr) * | 2000-10-12 | 2004-12-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Kristalin monohidrat, bunun imalat yöntemi ve bir ilaç maddesinin imalatında kullanımı |
DE10050995A1 (de) * | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
DE10050994A1 (de) * | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung |
DE10111843A1 (de) * | 2001-03-13 | 2002-09-19 | Boehringer Ingelheim Pharma | Verbindungen zur Behandlung von inflammatorischen Erkrankungen |
SI1401445T1 (sl) * | 2001-06-22 | 2007-02-28 | Boehringer Ingelheim Pharma | Kristalinicen antiholinergik, postopek za njegovo pripravo in njegova uporaba za pripravo zdravila |
DE10203749A1 (de) * | 2002-01-31 | 2003-08-14 | Boehringer Ingelheim Pharma | Neue Anticholinergika, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
DE10203741A1 (de) * | 2002-01-31 | 2003-08-14 | Boehringer Ingelheim Pharma | Neue Fluorencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
DE10203753A1 (de) * | 2002-01-31 | 2003-08-14 | Boehringer Ingelheim Pharma | Neue Xanthencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
US20030191158A1 (en) * | 2002-02-11 | 2003-10-09 | Magee Thomas V. | Nicotinamide derivatives and a tiotropium salt in combination for the treatment of diseases |
US7045534B2 (en) * | 2002-02-12 | 2006-05-16 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of reducing angiogenesis |
BR0308739A (pt) * | 2002-03-18 | 2005-01-11 | Schering Corp | Tratamentos em combinação para doenças mediadas por quimiocina |
NZ538493A (en) * | 2002-08-29 | 2007-10-26 | Cipla Ltd | Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids |
US7307076B2 (en) * | 2004-05-13 | 2007-12-11 | Boehringer Ingelheim International Gmbh | Beta agonists for the treatment of respiratory diseases |
US7517995B2 (en) * | 2006-04-06 | 2009-04-14 | Boehringer Ingelheim International Gmbh | Thiazolyl-dihydro-cyclopentapyrazole |
-
2004
- 2004-03-30 DE DE102004016179A patent/DE102004016179A1/de not_active Withdrawn
-
2005
- 2005-03-07 US US11/074,179 patent/US20060030579A1/en not_active Abandoned
- 2005-03-19 EP EP05716229A patent/EP1732553A1/de not_active Withdrawn
- 2005-03-19 WO PCT/EP2005/002946 patent/WO2005097126A1/de not_active Application Discontinuation
- 2005-03-19 CA CA002560131A patent/CA2560131A1/en not_active Abandoned
- 2005-03-19 JP JP2007505432A patent/JP2007530611A/ja active Pending
-
2010
- 2010-12-08 US US12/963,250 patent/US20110076238A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20110076238A1 (en) | 2011-03-31 |
WO2005097126A1 (de) | 2005-10-20 |
US20060030579A1 (en) | 2006-02-09 |
EP1732553A1 (de) | 2006-12-20 |
JP2007530611A (ja) | 2007-11-01 |
CA2560131A1 (en) | 2005-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007095050A3 (en) | N-hydroxyguanidines as modulators of indoleamine 2,3-dioxygenase | |
EA201000946A1 (ru) | Бициклические производные для применения при лечении состояний, связанных с андрогенным рецептором | |
GEP20084551B (en) | 4-phenylamino-quinazolin-6-yl-amides | |
ATE410424T1 (de) | Spirocyclische cyclohexan-derivate | |
ATE492542T1 (de) | Herstellung und anwendung von biphenyl-4-yl- carbonylaminosäurederivaten zur behandlung von obesitas | |
ATE376828T1 (de) | Verwendung von rotigotin zur behandlung und prävention des parkinson-plus-syndroms | |
ATE502633T1 (de) | Cyclosporins zur behandlung und vorbeugung von augenerkrankungen | |
TW200606162A (en) | Pyrazolopyridine derivatives | |
UA109459C2 (xx) | ПОХІДНІ 5,6-ДИГІДРОІМІДАЗО[1,2-a]ПІРАЗИН-8-ІЛАМІНУ, ПРИДАТНІ ЯК ІНГІБІТОРИ БЕТА-СЕКРЕТАЗИ (BACE) | |
ATE457027T1 (de) | Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht | |
TW200730515A (en) | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase | |
GEP201706786B (en) | Methods and drug products for treating alzheimer's disease | |
ATE539754T1 (de) | Arzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen | |
MX2010003949A (es) | N-fenil-bipirrolidina carboxamidas sustituidas y uso terapeutico de las mismas. | |
TW200628473A (en) | Novel heterocycles | |
DE102004016179A1 (de) | Verbindungen zur Behandlung von proliferativen Prozessen | |
DE10337184A1 (de) | Substituierte 3-Pyrrolidin-Indol-Derivate | |
ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
EA200801580A1 (ru) | Новые производные пирониндола и способ их получения | |
HK1146054A1 (en) | Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof | |
TW200740827A (en) | Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives | |
ATE462438T1 (de) | Verwendung von carrageenan zur behandlung von rhinovirus-infektionen | |
TW200637817A (en) | 5-aminoindole derivatives | |
MX366496B (es) | Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso. | |
MY146802A (en) | Novel drugs for treating respiratory diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R005 | Application deemed withdrawn due to failure to request examination |
Effective date: 20110331 |